Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

SciClone Pharmaceuticals Company Profile (NASDAQ:SCLN)

Consensus Ratings for SciClone Pharmaceuticals (NASDAQ:SCLN) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $8.00 (58.73% upside)

Analysts' Ratings History for SciClone Pharmaceuticals (NASDAQ:SCLN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/12/2013AegisLower Price TargetBuy$9.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
9/25/2013AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
8/9/2013TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/16/2013AegisUpgradeHold -> Buy$9.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2013AegisDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
9/18/2012BWS FinancialUpgradeHold -> Buy$8.25ViewTweet This Rating  Share This Rating on StockTwits
8/13/2012Cowen and CompanyDowngradeOutperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2012 forward)